Want to see TSE:KSI full AI Analyst Report?
KSI Stock Chart & Stats
C$6.50
-C$0.02(-0.23%)
At close: 4:00 PM EDT
C$6.50
-C$0.02(-0.23%)
Day’s Range― - ―
52-Week RangeC$3.23 - C$6.50
Previous CloseN/A
Volume97.57K
Average Volume (3M)120.08K
Market Cap
C$624.86M
Enterprise ValueC$309.58
Total Cash (Recent Filing)C$51.52M
Total Debt (Recent Filing)C$26.77M
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding96,132,080
10 Day Avg. Volume105,937
30 Day Avg. Volume120,085
Financial Highlights & Ratios
PEG Ratio2.75
Price to Book (P/B)7.18
Price to Sales (P/S)7.38
P/FCF Ratio38.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$6.50Price Target Upside0.00%
Rating ConsensusModerate Sell
Number of Analyst Covering2
EPS Forecast (FY)-0.09
Revenue Forecast (FY)C$78.55M
Bulls Say, Bears Say
Bulls Say
Top-line MomentumSustained ~5.1x TTM revenue growth indicates durable product-market fit in regulated industries. Strong recurring sales momentum supports scale economics, greater contract leverage, and provides a growing base for incremental margins and reinvestment over the next several quarters.
Healthy Gross Margins And Improving ProfitabilityHigh ~64% gross margins are consistent with software/subscription economics and enable investment in growth while retaining revenue share. Improving profitability trends reduce the structural gap to break-even and increase the chance of durable operating leverage as scale continues.
Recurring Subscription Model In Regulated MarketsA subscription/license model serving regulated life-sciences creates predictable recurring revenue and high switching costs due to validation and compliance needs. This structural business model supports retention, multi-site expansions, and long-term customer lifetime value.
Bears Say
Ongoing Net Losses And Negative EBITDespite revenue growth, persistent TTM net losses and negative EBIT mean the company still depends on capital or margin expansion to reach sustained profitability. This constrains reinvestment flexibility and extends the timeline for shareholder returns absent consistent margin improvement.
Negative And Volatile Free Cash FlowNegative and volatile free cash flow reduces self-funding capacity for growth and product investment. The return to negative FCF increases reliance on external financing and raises execution risk if top-line or margin improvements fluctuate over coming quarters.
Returns Remain Negative Despite Improved CapitalizationAlthough leverage has moderated, negative return on equity shows the balance sheet is not yet delivering shareholder value. Continued negative returns can limit capital allocation options and make future funding more expensive if profitability does not materialize.
kneat.com News
KSI FAQ
What was kneat.com’s price range in the past 12 months?
kneat.com lowest stock price was C$3.23 and its highest was C$6.50 in the past 12 months.
What is kneat.com’s market cap?
kneat.com’s market cap is C$624.86M.
When is kneat.com’s upcoming earnings report date?
kneat.com’s upcoming earnings report date is Nov 11, 2026 which is in 88 days.
How were kneat.com’s earnings last quarter?
Currently, no data Available
Is kneat.com overvalued?
According to Wall Street analysts kneat.com’s price is currently same.
Does kneat.com pay dividends?
kneat.com does not currently pay dividends.
What is kneat.com’s EPS estimate?
kneat.com’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does kneat.com have?
kneat.com has 96,132,080 shares outstanding.
What happened to kneat.com’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of kneat.com?
Currently, no hedge funds are holding shares in TSE:KSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
kneat.com Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
C$6.50 (0.00% )
C$6.50 (0.00% )
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
15.78%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.20%
Trailing 12-Months
Company Description
kneat.com
Kneat.com, Inc. develops and provides specialized software solutions for managing data and documents within highly regulated industries across the United States, Ireland, Canada, and other international markets. Its flagship product, the Kneat Gx platform, is a customizable, ready-to-use application designed to streamline validation lifecycle processes and critical testing procedures specifically for sectors such as biotechnology, pharmaceuticals, and medical device manufacturing. This robust platform supports a wide array of validation activities, including those for processes, computer systems, cleaning, analytical instruments, methods, utilities, facilities, equipment, and cold chains. It also facilitates commissioning, qualification, and electronic logbook management. Beyond its software, Kneat.com offers comprehensive services like user training, system installation, upgrades, ongoing maintenance, consulting, process mapping, and project management. The company's headquarters are located in Limerick, Ireland.
KSI Stock 12 Month Forecast
Average Price Target
C$6.50
▲(0.00% Upside)
Technical Analysis
Diagnos
―
Vitalhub
―
Rocket Doctor AI
―
UniDoc Health Corp
―
PanGenomic Health, Inc. Class A
―